Potential Use of Microarray Patches for Vaccine Delivery in Low- and Middle-Income Countries
This article, published in Vaccine, summarizes learnings obtained from discussions with stakeholders on how microarray patches (MAPs) could ease vaccine delivery and increase equitable access to vaccines in low- and middle-income countries (LMICs). It outlines the benefits and challenges associated with MAP vaccine delivery, current MAP product development status, results from acceptability studies, manufacturing considerations, regulatory pathways, and the value proposition of MAPs for vaccine delivery in LMICs. The authors conclude that MAPs have significant potential to improve vaccination coverage by overcoming barriers to vaccine delivery in LMICs.
Author: Peyraud N, Zehrung D, Jarrahian C, Frivold C, Orubu T, Giersing B
» Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Peyraud N, Zehrung D, Jarrahian C, Frivold C, Orubu T, Giersing B. Potential Use of Microarray Patches for Vaccine Delivery in Low- and Middle-Income Countries. Vaccine. 2019;37(32):4427-4434.
Resource types: Peer-reviewed journal
Diseases/vaccines: Not disease/vaccine specific